Cargando…

Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma

BACKGROUND: Positron emission tomography (PET) with F-18-labeled fluorodeoxyglucose (FDG) provides remarkable accuracy in detection, treatment monitoring and follow-up of systemic malignant lymphoma. Its value in the management of patients with primary central nervous system lymphoma (PCNSL) is less...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maza, Sofiane, Buchert, Ralph, Brenner, Winfried, Munz, Dieter Ludwig, Thiel, Eckhard, Korfel, Agnieszka, Kiewe, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Versita, Warsaw 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691084/ https://www.ncbi.nlm.nih.gov/pubmed/23801905 http://dx.doi.org/10.2478/raon-2013-0016

Ejemplares similares

Diagnosis and management of primary intraocular lymphoma: an update
por: Jahnke, Kristoph, et al.
Publicado: (2007)

Cerebral Toxoplasmosis Masquerading Cns Lymphoma on FDG PET-CT in Post Renal Transplant Patient
por: Mukherjee, Anirban, et al.
Publicado: (2017)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [(18)F]FDG PET
por: Hellwig, Sabine, et al.
Publicado: (2018)

The value of bone marrow biopsy for staging of patients with primary CNS lymphoma
por: Margold, Michelle, et al.
Publicado: (2021)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
por: Bayar, Melikşah, et al.
Publicado: (2021)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients
por: Birsen, Rudy, et al.
Publicado: (2018)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
por: Levin, Fedor, et al.
Publicado: (2021)

Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome
por: Seidel, Sabine, et al.
Publicado: (2021)

Isolated CNS relapse of medullary aggressive high-grade B-cell lymphoma on (18)F-FDG-PET/CT
por: Lambe, Gerard, et al.
Publicado: (2022)

FDG-PET in Follicular Lymphoma Management
por: Bodet-Milin, C., et al.
Publicado: (2012)

The role of FDG-PET in Hodgkin lymphoma
por: Subocz, Edyta, et al.
Publicado: (2017)

Appearance of CNS histoplasmosis on (18)F-FDG PET/CT with MRI correlation
por: Makis, William, et al.
Publicado: (2016)

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

Pulmonary intravascular lymphoma detected by FDG‐PET
por: Nada, Takahiro, et al.
Publicado: (2017)

Sarcoidosis mimicking lymphoma on FDG-PET imaging
por: Shetty, Anjali, et al.
Publicado: (2015)

Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

Spectrum of brain abnormalities detected on whole body F-18 FDG PET/CT in patients undergoing evaluation for non-CNS malignancies
por: Tripathi, Madhavi, et al.
Publicado: (2011)

HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis
por: Seidel, Sabine, et al.
Publicado: (2019)

(18)F-FDG PET/CT Findings of Non-Hodgkin Lymphoma Involving the Whole Genitourinary System
por: Oral, Aylin, et al.
Publicado: (2018)

Overview of early response assessment in lymphoma with FDG-PET
por: MacManus, Michael P, et al.
Publicado: (2007)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Interest of FDG-PET in the Management of Mantle Cell Lymphoma
por: Bailly, Clément, et al.
Publicado: (2019)

FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
por: Martineau, Patrick, et al.
Publicado: (2020)

18F-FDG PET/CT with unusual bone and CNS metastases from testicular seminoma
por: Gómez, Francisco Javier García, et al.
Publicado: (2015)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

(18) F-FDG Whole-Body PET-MR in Primary Hepatic Lymphoma Mimicking Focal Nodular Hyperplasia
por: Basheer, Shyma, et al.
Publicado: (2022)

Diagnostic performance of integrated whole-body (18)F-FDG PET/MRI for detecting bone marrow involvement in indolent lymphoma: Comparison with (18)F-FDG PET or MRI alone
por: Chen, Xuetao, et al.
Publicado: (2023)

[(18)F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [(18)F]FDG in human xenograft models
por: Hovhannisyan, Narinée, et al.
Publicado: (2018)

Optimized dose regimen for whole-body FDG-PET imaging
por: de Groot, Eleonore H, et al.
Publicado: (2013)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

Utility of FDG PET/CT in the Management of Primary Testicular Lymphoma
por: Okuyucu, Kürşat, et al.
Publicado: (2018)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake
por: Georgi, Thomas W, et al.
Publicado: (2022)

Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT
por: Herrmann, Ken, et al.
Publicado: (2015)

Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by (18)F-FDG PET/CT Imaging
por: Vlachopoulos, Charalambos V., et al.
Publicado: (2020)

Multicentric Castleman's disease: Closest mimic of lymphoma on FDG PET/CT
por: Puranik, Ameya D, et al.
Publicado: (2013)

FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management
por: Gallamini, Andrea, et al.
Publicado: (2017)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
por: Al Tabaa, Yassine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_or3q0gjunfogt4o2usg5m1hlaa